Search results for "Vaccinations"
ACP's commitment to address misinformation and disinformation
The College vigorously supports the use of science and scientific expertise, based on the best available evidence, and remains concerned about the spread of both disinformation and misinformation on social media, public news channels, and other digital channels.
https://immattersacp.org/weekly/archives/2023/02/14/5.htm
14 Feb 2023
Study shows shingles vaccine safe in patients taking TNF inhibitors
The safety and effectiveness of live virus vaccines, such as the varicella-zoster vaccine, have been unknown in patients with inflammatory diseases who are receiving immunomodulatory therapy.
https://immattersacp.org/weekly/archives/2021/09/28/4.htm
28 Sep 2021
Studies find monoclonal antibodies and remdesivir effective, while vaccine-associated myocarditis is rare
A trial of casirivimab plus imdevimab indicated it reduced risk of hospitalization or death, the CDC urged vaccination during pregnancy and updated its v-safe tool, and an analysis showed that postvaccine myocarditis occurred in men and resolved with conservative treatment.
https://immattersacp.org/weekly/archives/2021/10/05/1.htm
5 Oct 2021
Monoclonal antibodies appear safe as COVID-19 treatment during pregnancy
Pregnant patients who received monoclonal antibody treatments had no higher risk for adverse obstetric events but also no significant improvement on COVID-19-related outcomes, a retrospective study found.
https://immattersacp.org/weekly/archives/2022/11/15/2.htm
15 Nov 2022
New data on COVID-19 vaccines' effectiveness over time, boosters, barriers to uptake
Multiple recent studies assessed the effectiveness of the COVID-19 vaccines at different time intervals after vaccination, while others looked at the impact of booster shots. Results of a survey suggested that racial differences in vaccine uptake may be attributable to social barriers.
https://immattersacp.org/weekly/archives/2021/12/07/1.htm
7 Dec 2021
New recommendations for high-risk outpatients; data on omicron and boosters, breakthrough infections, myocarditis
The NIH updated its COVID-19 treatment guidelines for high-risk outpatients in response to the omicron variant, recommending the combination of ritonavir-nirmatrelvir above other options, and studies showed the effect of a booster dose. ACP practice points and new research looked at immunity conferred by infection or vaccination. Two studies quantified association of carditis with the mRNA vaccines.
https://immattersacp.org/weekly/archives/2022/01/25/1.htm
25 Jan 2022
Advice on monoclonal antibodies; new data on long-term COVID-19 symptoms, vaccine efficacy
The NIH offered guidance on prioritization when monoclonal antibodies can't be given to all eligible patients. Two studies looked at patients with persistent COVID-19 symptoms, and other research confirmed the safety and effectiveness of the vaccines, even with the delta variant.
https://immattersacp.org/weekly/archives/2021/09/14/2.htm
14 Sep 2021
ACG updates, reaffirms guidelines on evaluation, management of patients with celiac disease
The diagnostic approach to celiac disease in adults using serological and histologic data remains unchanged from the American College of Gastroenterology's (ACG) 2013 clinical guidelines.
https://immattersacp.org/weekly/archives/2023/01/17/1.htm
17 Jan 2023
New COVID-19 boosters authorized and recommended
The CDC has recommended the new formulations of the mRNA vaccines, targeted at the BA.4 and BA.5 lineages of the omicron variant, for adults and adolescents who last received a COVID-19 shot at least two months ago.
https://immattersacp.org/weekly/archives/2022/09/06/2.htm
6 Sep 2022
CDC releases interim monkeypox guidance, reports epidemiologic and clinical characteristics
The interim guidance focused on prevention and treatment of monkeypox in persons with HIV infection. The most frequently reported signs and symptoms from recent cases of monkeypox in the U.S. include rash (100%), fever (63%), chills (59%), and lymphadenopathy (59%).
https://immattersacp.org/weekly/archives/2022/08/16/1.htm
16 Aug 2022